Aligos Therapeutics (NASDAQ:ALGS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently ...

Aligos Therapeutics (ALGS) announced positive data from three oral presentations at the 34th Annual Meeting of the Asian Pacific Association ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever 60.4% of Aligos Therapeutics shares are held by institutional investors.

We've identified the following companies as similar to Aligos Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics ...

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

A Belgian MMA fighter and his Thai wife speak to reporters on March 19 about the brawl captured in the viral clip, at the scene of the incident in Pattaya. PATTAYA — A viral video showing a lone ...

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its strategic reboot. The company will henceforth be known as Whitehawk ...

Belgium and Rwanda announced the expulsion of each other’s diplomats, as relations deteriorated over allegations about their respective roles in the conflict in the eastern Democratic Republic of ...

Belgium has successfully pushed the EU to impose sanctions on its former colony, Rwanda, over its military involvement in DR Congo. Rwanda has not taken the decision ...